Antonio Palumbo, MD

Chief, Myeloma Unit
Department of Oncology
University of Torino
Torino, Italy

Dr. Antonio Palumbo received his medical degree from the University of Torino, Italy, where he served his residency in internal medicine and held a fellowship in hematology/oncology. Before his current position as chief of the Myeloma Unit of the Department of Oncology, Section of Hematology at the University of Torino, Dr. Palumbo was a research associate at the Wistar Institute, University of Pennsylvania.

In addition to membership in numerous professional organizations, including the Italian Society of Hematology, Italian Society of Experimental Hematology, European Society of Hematology, American Society of Hematology, and the American Society of Clinical Oncology, Dr. Palumbo is on the Board of Directors of the International Myeloma Society. He has authored more than 150 publications in peer-reviewed journals as well numerous abstract and several textbooks chapters. Dr. Palumbo specializes in malignant hematology and medical oncology and has clinical and research interest in plasma cell dyscrasia, his current research focuses on the pathogenesis and treatment of multiple myeloma.

Faculty Disclosure
Dr. Antonio Palumbo has received honoraria related to formal advisory activities from Celgene Corporation and Janssen-Cilag EMEA, as well as honoraria related to speakers’ bureau activities from Merck & Co., Inc. and Amgen Inc.

Last modified: March 23, 2021